These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 7928833

  • 1. Development of antibacterial resistance: the Dutch experience.
    Beunders AJ.
    J Antimicrob Chemother; 1994 May; 33 Suppl A():17-22. PubMed ID: 7928833
    [Abstract] [Full Text] [Related]

  • 2. Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands.
    Goettsch W, van Pelt W, Nagelkerke N, Hendrix MG, Buiting AG, Petit PL, Sabbe LJ, van Griethuysen AJ, de Neeling AJ.
    J Antimicrob Chemother; 2000 Aug; 46(2):223-8. PubMed ID: 10933644
    [Abstract] [Full Text] [Related]

  • 3. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group.
    Zhanel GG, Karlowsky JA, Harding GK, Carrie A, Mazzulli T, Low DE, Hoban DJ.
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1089-92. PubMed ID: 10722520
    [Abstract] [Full Text] [Related]

  • 4. Urinary tract-derived Escherichia coli resistant to co-trimoxazole in Japan, where the drug is seldom used for treating acute urinary tract infections.
    Ishihara S, Yokoi S, Masue N, Yamada T, Minamidate Y, Yasuda M, Nakano M, Deguchi T.
    J Antimicrob Chemother; 2002 May; 49(5):881-2. PubMed ID: 12003990
    [No Abstract] [Full Text] [Related]

  • 5. Use of other antimicrobial drugs is associated with trimethoprim resistance in patients with urinary tract infections caused by E. coli.
    Mulder M, Verbon A, Lous J, Goessens W, Stricker BH.
    Eur J Clin Microbiol Infect Dis; 2019 Dec; 38(12):2283-2290. PubMed ID: 31494829
    [Abstract] [Full Text] [Related]

  • 6. [Nitrofurans: a modern treatment for uncomplicated urinary infections?].
    Cahen P, Honderlick P.
    Pathol Biol (Paris); 2000 Jun; 48(5):470-1. PubMed ID: 10949843
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States.
    Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF.
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2540-5. PubMed ID: 12121930
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections.
    Olson RP, Harrell LJ, Kaye KS.
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1285-6. PubMed ID: 19104022
    [Abstract] [Full Text] [Related]

  • 12. Escherichia coli antimicrobial susceptibility profile and cumulative antibiogram to guide empirical treatment of uncomplicated urinary tract infections in women in the province of Québec, 2010-15.
    Delisle G, Quach C, Domingo MC, Boudreault AA, Gourdeau M, Bernatchez H, Lavallée C.
    J Antimicrob Chemother; 2016 Dec; 71(12):3562-3567. PubMed ID: 27494927
    [Abstract] [Full Text] [Related]

  • 13. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group.
    Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW.
    N Engl J Med; 2001 Oct 04; 345(14):1007-13. PubMed ID: 11586952
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
    Yüksel S, Oztürk B, Kavaz A, Ozçakar ZB, Acar B, Güriz H, Aysev D, Ekim M, Yalçinkaya F.
    Int J Antimicrob Agents; 2006 Nov 04; 28(5):413-6. PubMed ID: 17000085
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Why not performing susceptibility test for trimethoprim-sulphamethoxazole?
    Hagiya H.
    J Chemother; 2015 Feb 04; 27(2):124-5. PubMed ID: 25248022
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.